Pan-cancer (ca) analysis of the safety and efficacy of immune checkpoint inhibitors (ICI) in patients (pts) living with HIV (PLWH): Results from the international CATCH-IT consortium.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Talal El Zarif, Amin Nassar, Elio Adib, Jiaming Huang, Rana R. McKay, Ryan Dobbs, Nazli Dizman, Claire Drolen, Elie Kozaily, Anwaar Saeed, Caroline Nebhan, Michael Lorentsen, Javier Baena, Alessia Dalla Pria, Lindsey Baden, Ramya Ramaswami, Toni K. Choueiri, Kathryn Anne Lurain, Guru P. Sonpavde, Abdul Rafeh Naqash
Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center, University of California San Diego, John H. Stroger, Jr. Hospital of Cook County, Cook County Health and Hospitals System, City Of Hope National Medical Center, University of California, Los Angeles, Indiana University School of Medicine, The University of Kansas Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of North Carolina Health Care, Hospital Universitario 12 De Octubre, Chelsea and Westminster Hospital, Hammersmith Hospital, Imperial College London, National Institutes of Health, National Cancer Institute, University of Oklahoma Medical Center, OU Health Stephenson Cancer Center, University of Oklahoma
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4286297439